KD Logo

Taking a look at what insiders are doing to gauge the Ultragenyx Pharmaceutical Inc (RARE)’s direction

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ultragenyx Pharmaceutical Inc shares valued at $128,215 were purchased by Parschauer Karah Herdman on Feb 27 ’25. At $42.88 per share, Parschauer Karah Herdman acquired 2,990 shares.

Also, KAKKIS EMIL D sold 11,727 shares, netting a total of over 495,231 in proceeds. Following the sale of shares at $42.23 each, the insider now holds 2,183,985 shares.

Before that, KAKKIS EMIL D had added 11,727 shares to its account. In a trade valued at $495,264, the Officer bought Ultragenyx Pharmaceutical Inc shares for $42.23 each.

As published in a research note from Goldman on June 06, 2024, Ultragenyx Pharmaceutical Inc [RARE] has been rated up from a Neutral to a Buy and the price target has been revised to $67 from $56. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late April. As of December 08, 2023, Wells Fargo has initiated its “an Overweight” rating for RARE.

Analyzing RARE Stock Performance

During the last five days, there has been a drop of approximately -5.64%. Over the course of the year, Ultragenyx Pharmaceutical Inc shares have dropped approximately -0.24%. Shares of the company reached a 52-week high of $46.50 on 02/06/25 and a 52-week low of $39.74 on 02/25/25. A 50-day SMA is recorded $43.15, while a 200-day SMA reached $47.24. Nevertheless, trading volume fell to 0.62 million shares from 0.69 million shares the previous day.

Support And Resistance Levels for Ultragenyx Pharmaceutical Inc (RARE)

According to the 24-hour chart, there is a support level at 41.25, which, if violated, would cause prices to drop to 40.54. In the upper region, resistance lies at 43.11. The next price resistance is at 44.26. RSI (Relative Strength Index) is 44.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.71, which suggests the price will decrease in the coming days. Percent R is at 65.85%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular